Australia markets closed
  • ALL ORDS

    7,624.30
    +23.80 (+0.31%)
     
  • ASX 200

    7,368.90
    +9.90 (+0.13%)
     
  • AUD/USD

    0.7487
    -0.0064 (-0.85%)
     
  • OIL

    71.50
    +0.46 (+0.65%)
     
  • GOLD

    1,763.90
    -10.90 (-0.61%)
     
  • BTC-AUD

    47,156.59
    -886.98 (-1.85%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • AUD/EUR

    0.6308
    -0.0028 (-0.44%)
     
  • AUD/NZD

    1.0787
    +0.0009 (+0.09%)
     
  • NZX 50

    12,551.93
    +10.73 (+0.09%)
     
  • NASDAQ

    14,049.58
    -114.22 (-0.81%)
     
  • FTSE

    7,017.47
    -135.96 (-1.90%)
     
  • Dow Jones

    33,290.08
    -533.37 (-1.58%)
     
  • DAX

    15,448.04
    -279.63 (-1.78%)
     
  • Hang Seng

    28,801.27
    +242.68 (+0.85%)
     
  • NIKKEI 225

    28,964.08
    -54.25 (-0.19%)
     

Global Huntington's Disease Markets, Epidemiology and Patient Flow Report 2020-2035 - ResearchAndMarkets.com

·2-min read

The "Global Huntington's Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Huntington's Disease Epidemiology and Patient Flow Analysis - 2021, provides Huntington's Disease epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Huntington's Disease patients, history of the disease at the population level (Huntington's Disease prevalence, Huntington's Disease incidence) and at the clinical level (from diagnosis to treated patients).

It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Huntington's Disease patient flow: Huntington's Disease prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Huntington's Disease patients by age group, gender

  • Forecast: Huntington's Disease epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Huntington's Disease market sizing, assessing market potential, and developing drug forecast models

  • Identify Huntington's Disease patients segments through age groups, gender, and disease sub-types

  • Develop Huntington's Disease population-based health management frameworks

  • Evaluate Huntington's Disease market opportunities, identify target patient population

  • Align marketing decisions with the Huntington's Disease target population

  • Communicate leadership and health authorities about your Huntington's Disease target patient population

Key Topics Covered:

1. Research Methodology

2. Huntington's Disease Patients Definition

3. US Huntington's Disease Epidemiology and Patient Flow

4. Germany Huntington's Disease Epidemiology and Patient Flow

5. France Huntington's Disease Epidemiology and Patient Flow

6. Italy Huntington's Disease Epidemiology and Patient Flow

7. Spain Huntington's Disease Epidemiology and Patient Flow

8. UK Huntington's Disease Epidemiology and Patient Flow

9. Europe Huntington's Disease Epidemiology and Patient Flow

10. Japan Huntington's Disease Epidemiology and Patient Flow

11. Global Huntington's Disease Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/v0qy7y

View source version on businesswire.com: https://www.businesswire.com/news/home/20210511005627/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting